The Tissue Bank has helped drive cutting-edge research in early detection, enhanced diagnosis and therapeutics to help people live well with and beyond the disease.

To add to this catalogue, please complete our online form. Our return catalogue, records publications, links to molecular data generated, PhD projects and public engagement activities (e.g., talk and posters).

Project Title
BCNTB bioinformatics: the next evolutionary step in the bioinformatics of breast cancer tissue banking
BCCTBbp: the Breast Cancer Campaign Tissue Bank bioinformatics portal
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects
Aurora Kinase A Is an independent predictor of invasive recurrence in breast ductal carcinoma in situ
Breast cancer: Investment biobanking--increased returns from tissue samples
TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression
Detection of involved margins in breast specimens with X-ray phase-contrast computed tomography
Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer
Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway
A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer
Adding value to rare tissue samples donated to biobanks: characterisation of breast tissue and primary cell cultures obtained from a female-to-male transgender patient
Genomics England: Breast Cancer
Role of IKK alpha in triple negative breast cancer
Dynamic biobanking for advancing breast cancer research
Characterization of the immune microenvironment in inflammatory breast cancer using multiplex immunofluorescence immunofluorescence
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
Reciprocal Interactions Between the Gut Microbiome and Mammary Tissue Mast Cells Promote Metastatic Dissemination of HR+ Breast Tumors
Field cancerization in breast cancer
Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion
Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer
Cancer-associated fibroblasts induce an aggressive phenotypic shift in non-malignant breast epithelial cells via interleukin-8 and S100A8
MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells
Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors
Tumor-infiltrating B lymphocyte profiling identifies IgG-biased, clonally expanded prognostic phenotypes in triple-negative breast cancer
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
CAFs and cancer cells co-Migration in 3D spheroid invasion assay
Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts
Cytoplasmic cyclin E Is an independent marker of aggressive tumor biology and breast cancer-specific mortality in women over 70 years of age
Co-expression effect of SLC7A5/SLC3A2 to predict response to endocrine therapy in oestrogen-receptor-positive breast cancer
SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells
The sodium channel β1 subunit mediates outgrowth of neurite-like processes on breast cancer cells and promotes tumour growth and metastasis
Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens
Glucocorticoid receptor expression predicts good outcome in response to taxane-free, anthracycline-based therapy in triple negative breast cancer
Subcellular mRNA localization regulates ribosome biogenesis in migrating cells
Tumour promoting HER2 splice variant Δ16HER2: Regulation and implication in breast cancer
Reciprocal interactions between the gut microbiome and mammary tissue mast cells promote metastatic dissemination of HR+ breast tumor
Defining the role of MYBL2 in breast cancer progression
Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues